New blood filter may boost survival in septic shock patients on dialysis

NCT ID NCT07569406

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked back at 400 critically ill patients with septic shock and kidney failure who needed dialysis. Researchers compared those who received a special filter (Oxiris) that removes toxins and inflammation-causing substances to those who got standard filters. The goal was to see if the Oxiris filter was linked to better survival and kidney recovery. The study is complete, but because it is a retrospective review, it cannot prove cause and effect.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Oxiris filter (a special blood filter that removes toxins and inflammation-causing substances during dialysis)
What this could lead to
If the Oxiris filter is shown to improve survival and kidney recovery, it could become a standard tool for treating septic shock in intensive care.
What could go wrong
This is a retrospective study, not a controlled trial, so results may be influenced by other factors. The filter is already available, but its benefit over standard filters remains uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clínica Universidad de Navarra

    Pamplona, Navarre, 31008, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.